Company Filing History:
Years Active: 1999-2000
Title: Innovations in Hemoglobin Therapy by Gary R Marchand
Introduction
Gary R Marchand is a notable inventor based in Crystal Lake, IL (US). He has made significant contributions to the field of medical therapies, particularly in the area of hemodialysis. With a total of 2 patents, his work focuses on improving patient outcomes during critical medical procedures.
Latest Patents
One of his latest patents involves a novel approach to hemoglobin therapy in hemodialysis. This therapy utilizes low doses of stroma-free diaspirin cross-linked hemoglobin administered to patients undergoing hemodialysis. The primary goal is to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Furthermore, when implemented prophylactically, this hemoglobin therapy can partially obviate the need for further interventions to control circulatory system instability.
Career Highlights
Gary R Marchand is associated with Baxter International Inc., a leading company in the healthcare sector. His work at Baxter has allowed him to focus on innovative solutions that enhance patient care and safety during hemodialysis procedures.
Collaborations
Some of his notable coworkers include John D Blue and Jan W Garber, who have likely contributed to the collaborative efforts in advancing medical therapies.
Conclusion
In summary, Gary R Marchand's contributions to hemoglobin therapy in hemodialysis represent a significant advancement in medical innovation. His patents reflect a commitment to improving patient care and outcomes in critical healthcare settings.